{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T05:25:22Z","timestamp":1787117122235,"version":"build-2736575974"},"reference-count":37,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T00:00:00Z","timestamp":1787097600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Background and aim<\/jats:title>\n                    <jats:p>Repulsive guidance molecule-A (RGMa) is well-known for its roles in T-cell-mediated neuroinflammation and CNS repair. Innate-adaptive immune interactions, particularly between neutrophils and Th17 cells, are emerging as critical drivers of neuroinflammatory pathology in multiple sclerosis (MS). Whether RGMa regulates these neutrophil-associated Th17 responses remains largely unknown. Elucidating this mechanism may reveal novel therapeutic targets for MS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Serum levels of RGMa, BMP4, neutrophil elastase (NE), IL-17A, and inflammatory markers were measured in 10 relapsing-remitting MS patients during acute relapse and remission phases, and in 10 healthy controls.\n                      <jats:italic>In vitro<\/jats:italic>\n                      transwell co-cultures using primary human neutrophils and CD3\n                      <jats:sup>+<\/jats:sup>\n                      T cells were employed to evaluate the effects of RGMa monoclonal antibody (RGMa-mAb) treatment on neutrophil activation, Th17-associated responses, and T-cell migration. In parallel, experimental autoimmune encephalomyelitis (EAE) mice were treated with RGMa-mAb to assess neuroinflammation and BMP4-SMAD-related signaling changes\n                      <jats:italic>in vivo<\/jats:italic>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Serum RGMa and NE were elevated in acute-phase MS patients versus both remission and healthy controls (\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0&amp;lt;\u00a00.05), whereas IL-17A was elevated versus healthy controls (\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0&amp;lt;\u00a00.05). Correlation analyses showed that RGMa levels were positively associated with the neutrophil activation marker NE (\n                      <jats:italic>r<\/jats:italic>\n                      \u00a0=\u00a00.71), while serum Ly6G6D levels were correlated with IL-17A levels (\n                      <jats:italic>r<\/jats:italic>\n                      \u00a0=\u00a00.66), suggesting a potential link between neutrophil-associated inflammatory responses and Th17 activation during active disease.\n                      <jats:italic>In vitro<\/jats:italic>\n                      , RGMa-mAb treatment attenuated PMA-induced neutrophil activation, reduced Th17-associated inflammatory responses, and suppressed T-cell migration in the co-culture system. In EAE mice, RGMa-mAb ameliorated neurological deficits, decreased neutrophil- and Th17-associated inflammatory markers, and modulated BMP4-SMAD signaling.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>RGMa contributes to neutrophil-associated Th17 inflammatory responses in CNS autoimmunity, potentially in association with BMP4-SMAD signaling. Targeting RGMa may therefore represent a potential therapeutic strategy for MS-associated neuroinflammation that warrants further investigation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1941039","type":"journal-article","created":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T04:39:25Z","timestamp":1787114365000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Repulsive guidance molecule-a regulates neutrophil-associated Th17 responses in CNS autoimmunity"],"prefix":"10.3389","volume":"17","author":[{"given":"Weizhe","family":"Zhen","sequence":"first","affiliation":[{"name":"Graduate School, Capital Medical University, Department of Neurology, China-Japan Friendship Hospital","place":["Beijing, China"]},{"name":"Graduate School, Beijing University of Chinese Medicine","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyi","family":"Yang","sequence":"additional","affiliation":[{"name":"Graduate School, Capital Medical University, Department of Neurology, China-Japan Friendship Hospital","place":["Beijing, China"]},{"name":"Department of Neurology, China-Japan Friendship Hospital","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinsong","family":"Jiao","sequence":"additional","affiliation":[{"name":"Department of Neurology, China-Japan Friendship Hospital","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Cui","sequence":"additional","affiliation":[{"name":"Department of Neurology, China-Japan Friendship Hospital","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miaoxin","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Neurology, China-Japan Friendship Hospital","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Neurology, China-Japan Friendship Hospital","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dianjia","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Neurology, China-Japan Friendship Hospital","place":["Beijing, China"]},{"name":"Graduate School, Chinese Academy of Medical Sciences and Peking Union Medical College","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dantao","family":"Peng","sequence":"additional","affiliation":[{"name":"Department of Neurology, China-Japan Friendship Hospital","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Jin","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, China-Japan Friendship Hospital","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lai","family":"Wei","sequence":"additional","affiliation":[{"name":"Guangdong Provincial Key Laboratory of Allergy and Clinical Immunology, Institute of Ophthalmology, The Second Affiliated Hospital, Guangzhou Medical University","place":["Guangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weihe","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Neurology, China-Japan Friendship Hospital","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(18)30481-1","article-title":"Multiple sclerosis","volume":"391","author":"Thompson","year":"2018","journal-title":"Lancet"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1401483","article-title":"Multiple sclerosis","volume":"378","author":"Reich","year":"2018","journal-title":"N Engl J Med"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2018.01.021","article-title":"Multiple sclerosis: Mechanisms and immunotherapy","volume":"97","author":"Baecher-Allan","year":"2018","journal-title":"Neuron"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1177\/17562864211007687","article-title":"Inflammation in multiple sclerosis","volume":"14","author":"Haase","year":"2021","journal-title":"Ther Adv Neurol Disord"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1016\/j.amjmed.2020.05.049","article-title":"Treatment of multiple sclerosis: A review","volume":"133","author":"Hauser","year":"2020","journal-title":"Am J Med"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3390\/ijms242015273","article-title":"Histamine H4 receptor antagonist ameliorates the progression of experimental autoimmune encephalomyelitis via regulation of T-cell imbalance","volume":"24","author":"Aldossari","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241612991","article-title":"Histamine H4 receptor agonist, 4-methylhistamine, aggravates disease progression and promotes pro-inflammatory signaling in B cells in an experimental autoimmune encephalomyelitis mouse model","volume":"24","author":"Alsaad","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2020.102647","article-title":"The role of TH17 cells in multiple sclerosis: Therapeutic implications","volume":"19","author":"Moser","year":"2020","journal-title":"Autoimmun Rev"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1016\/j.cell.2020.02.035","article-title":"Propionic acid shapes the multiple sclerosis disease course by an immunomodulatory mechanism","volume":"180","author":"Duscha","year":"2020","journal-title":"Cell"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1007\/s11481-015-9614-0","article-title":"Multiple sclerosis and T lymphocytes: An entangled story","volume":"10","author":"Legroux","year":"2015","journal-title":"J Neuroimmune Pharmacol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.110094","article-title":"Interleukin-17 affects synaptic plasticity and cognition in an experimental model of multiple sclerosis","volume":"37","author":"Di Filippo","year":"2021","journal-title":"Cell Rep"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2023.176086","article-title":"MAP kinase inhibitor PD98059 regulates Th1, Th9, Th17, and natural T regulatory cells in an experimental autoimmune encephalomyelitis mouse model of multiple sclerosis","volume":"959","author":"Ahmad","year":"2023","journal-title":"Eur J Pharmacol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2022.02.017","article-title":"CCR1 antagonist ameliorates experimental autoimmune encephalomyelitis by inhibition of Th9\/Th22-related markers in the brain and periphery","volume":"144","author":"Al-Mazroua","year":"2022","journal-title":"Mol Immunol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1080\/08923973.2024.2330642","article-title":"Immunopathogenesis of multiple sclerosis: Molecular and cellular mechanisms and new immunotherapeutic approaches","volume":"46","author":"Aliyu","year":"2024","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2024.106744","article-title":"Temporal dynamics of neutrophil functions in multiple sclerosis","volume":"203","author":"Shen","year":"2024","journal-title":"Neurobiol Dis"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20221751","article-title":"Neutrophil extracellular traps and extracellular histones potentiate IL-17 inflammation in periodontitis","volume":"220","author":"Kim","year":"2023","journal-title":"J Exp Med"},{"key":"B17","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/s41577-022-00746-9","article-title":"IL-17 and IL-17-producing cells in protection versus pathology","volume":"23","author":"Mills","year":"2023","journal-title":"Nat Rev Immunol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2010.102","article-title":"The Th17 immune response in renal inflammation","volume":"77","author":"Turner","year":"2010","journal-title":"Kidney Int"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2321","article-title":"RGMa modulates T cell responses and is involved in autoimmune encephalomyelitis","volume":"17","author":"Muramatsu","year":"2011","journal-title":"Nat Med"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1523\/jneurosci.0084-17.2017","article-title":"Repulsive guidance molecule a (RGMa) induces neuropathological and behavioral changes that closely resemble Parkinson's disease","volume":"37","author":"Korecka","year":"2017","journal-title":"J Neurosci"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2022.12601","article-title":"RGMa regulates CCL5 expression via the BMP receptor in experimental autoimmune encephalomyelitis mice and endothelial cells","volume":"25","author":"Tang","year":"2022","journal-title":"Mol Med Rep"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.861486","article-title":"RGMa participates in the blood-brain barrier dysfunction through BMP\/BMPR\/YAP signaling in multiple sclerosis","volume":"13","author":"Zhang","year":"2022","journal-title":"Front Immunol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/s1474-4422(17)30470-2","article-title":"Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria","volume":"17","author":"Thompson","year":"2018","journal-title":"Lancet Neurol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1038\/s41467-022-28172-4","article-title":"Neutrophil extracellular traps and their histones promote Th17 cell differentiation directly via TLR2","volume":"13","author":"Wilson","year":"2022","journal-title":"Nat Commun"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaa8064","article-title":"Inflammation. Neutrophil extracellular traps license macrophages for cytokine production in atherosclerosis","volume":"349","author":"Warnatsch","year":"2015","journal-title":"Science"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhazmat.2025.137257","article-title":"Interleukin-33 modulates NET formation via an autophagy-dependent manner to promote neutrophilic inflammation in cigarette smoke-exposure asthma","volume":"487","author":"Liu","year":"2025","journal-title":"J Hazard Mater"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-025-04840-6","article-title":"Pilot exploration of RGMa-BMP4 signaling in neutrophil activation in NMOSD: Integrating clinical and molecular insights","volume":"62","author":"Zhang","year":"2025","journal-title":"Mol Neurobiol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1242\/dev.201642","article-title":"Axon guidance genes control hepatic artery development","volume":"150","author":"Gannoun","year":"2023","journal-title":"Development"},{"key":"B29","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.brainresbull.2023.01.003","article-title":"Mitogen-activated protein kinase inhibitor PD98059 improves neuroimmune dysfunction in experimental autoimmune encephalomyelitis in SJL\/J mice through the inhibition of nuclear factor-kappa B signaling in B cells","volume":"194","author":"Alomar","year":"2023","journal-title":"Brain Res Bull"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2022.113997","article-title":"Cathepsin B inhibitor alleviates Th1, Th17, and Th22 transcription factor signaling dysregulation in experimental autoimmune encephalomyelitis","volume":"351","author":"Ansari","year":"2022","journal-title":"Exp Neurol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2023.104658","article-title":"S3I-201, a selective stat3 inhibitor, ameliorates clinical symptoms in a mouse model of experimental autoimmune encephalomyelitis through the regulation of multiple intracellular signalling in Th1, Th17, and treg cells","volume":"73","author":"Ahmad","year":"2023","journal-title":"Mult Scler Relat Disord"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11061511","article-title":"DAPTA, a C-C chemokine receptor 5 (CCR5), leads to the downregulation of Notch\/NF-\u03baB signaling and proinflammatory mediators in CD40(+) cells in experimental autoimmune encephalomyelitis model in SJL\/J mice","volume":"11","author":"Alghibiwi","year":"2023","journal-title":"Biomedicines"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0032791","article-title":"Identification of the neogenin-binding site on the repulsive guidance molecule A","volume":"7","author":"Itokazu","year":"2012","journal-title":"PloS One"},{"key":"B34","doi-asserted-by":"publisher","first-page":"8628","DOI":"10.1038\/s41467-024-53038-2","article-title":"Distinctive CD39(+)CD9(+) lung interstitial macrophages suppress IL-23\/Th17-mediated neutrophilic asthma by inhibiting NETosis","volume":"15","author":"Han","year":"2024","journal-title":"Nat Commun"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2022.2153534","article-title":"Regulatory T cell therapy for multiple sclerosis: Breaching (blood-brain) barriers","volume":"18","author":"Verreycken","year":"2022","journal-title":"Hum Vaccin Immunother"},{"key":"B36","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/s41598-017-18362-2","article-title":"Inhibition of RGMa alleviates symptoms in a rat model of neuromyelitis optica","volume":"8","author":"Harada","year":"2018","journal-title":"Sci Rep"},{"key":"B37","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1002\/ana.27262","article-title":"Randomized, double-blind, placebo-controlled, multiple-dose studies to assess the safety and efficacy of elezanumab when added to standard of care in relapsing and progressive forms of multiple sclerosis","volume":"98","author":"Cree","year":"2025","journal-title":"Ann Neurol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1941039\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T04:39:31Z","timestamp":1787114371000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1941039\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,19]]},"references-count":37,"alternative-id":["10.3389\/fimmu.2026.1941039"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1941039","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,19]]},"article-number":"1941039"}}